These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7239000)

  • 1. Differential interaction of antiestrogens with cytosol estrogen receptors.
    Black LJ; Jones CD; Goode RL
    Mol Cell Endocrinol; 1981 Apr; 22(1):95-103. PubMed ID: 7239000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immobilized antiestrogen binds a specific uterine protein in addition to estrogen receptor proteins.
    Van Oosbree TR; Olsen MR; Tate AC; Jordan VC; Mueller GC
    Mol Cell Endocrinol; 1984 May; 35(2-3):143-9. PubMed ID: 6734928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.
    Black LJ; Goode RL
    Endocrinology; 1981 Sep; 109(3):987-9. PubMed ID: 7262030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
    Jordan VC; Gosden B
    J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular effects of antiestrogens (tamoxifen and LY117018) on estrogen-dependent glycoprotein (USP-1) synthesized and secreted by rat uterine epithelial cells.
    Takeda A; Shimizu S
    Endocrinology; 1988 Jul; 123(1):258-63. PubMed ID: 3383775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
    Jordan VC; Gosden B
    Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity binding of the antiestrogen [3H]tamoxifen to the 8S estradiol receptor.
    Capony F; Rochefort H
    Mol Cell Endocrinol; 1978; 11(2):181-98. PubMed ID: 680340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
    Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
    J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of the antiestrogen [3H]H1285 with the two forms of the molybdate-stabilized calf uterine estrogen receptor.
    Keene JL; Ruh MF; Ruh TS
    J Steroid Biochem; 1984 Dec; 21(6):625-31. PubMed ID: 6527530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential binding of antiestrogens by rat uterine and chick oviduct cytosol.
    Sutherland RL; Foo MS
    Biochem Biophys Res Commun; 1979 Nov; 91(1):183-91. PubMed ID: 518621
    [No Abstract]   [Full Text] [Related]  

  • 12. Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice.
    Black LJ; Goode RL
    Life Sci; 1980 Apr; 26(17):1453-8. PubMed ID: 7382727
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL; Scali J
    J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counteraction of estradiol-induced activation of tissue-type plasminogen activator in a human breast cancer cell line by an anti-estrogen, LY117018.
    Uchiumi T; Mizoguchi H; Hagino Y; Kohno K; Kuwano M
    Int J Cancer; 1991 Jan; 47(1):80-5. PubMed ID: 1702405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroidal antioestrogens--receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells.
    Wakeling AE; Valcaccia B; Newboult E; Green LR
    J Steroid Biochem; 1984 Jan; 20(1):111-20. PubMed ID: 6538611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of new hydroxylated triphenylethylene (TPE) derivatives on estradiol binding to uterine cytosol.
    Pons M; Michel F; Crastes de Paulet A; Gilbert J; Miquel JF; Précigoux G; Hospital M; Ojasoo T; Raynaud JP
    J Steroid Biochem; 1984 Jan; 20(1):137-45. PubMed ID: 6423897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus.
    Garcia M; Greene G; Rochefort H; Jensen EV
    Endocrinology; 1982 Apr; 110(4):1355-61. PubMed ID: 7060530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiestrogens. 3. Estrogen receptor affinities and antiproliferative effects in MCF-7 cells of phenolic analogues of trioxifene, [3,4-dihydro-2-(4- methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]- phenyl]methanone.
    Jones CD; Blaszczak LC; Goettel ME; Suarez T; Crowell TA; Mabry TE; Ruenitz PC; Srivatsan V
    J Med Chem; 1992 Mar; 35(5):931-8. PubMed ID: 1548683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical and genetic evidence for specific antiestrogen binding sites.
    Faye JC; Jozan S; Redeuilh G; Baulieu EE; Bayard F
    Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3158-62. PubMed ID: 6574477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.